Taste cells, like other sensory cells, transduce environmental stimuli into membrane conductance changes, but definitive mechanisms are unclear. This project aims to clone a taste receptor and other gustatory signaling molecules in order to characterize the molecular mechanisms of taste. To isolate a sweetness receptor through expression cloning, a human genomic library and a cDNA expression library from taste receptor cells will be screened using a variety of affinity selection techniques involving sweet proteins. Since these receptors are highly tissue restricted, elucidation of their sequence and structure has proved difficult. To isolate gustatory signaling molecules, a taste cell specific expression library will be screened using a yeast two hybrid system. The second phase of the project, to study signal transduction initiated by activation of the sweetness receptor, will involve expression of mutated proteins. Though our specific goal is to clone the sweetness receptor, the proposal emphasizes the learning of molecular strategies generally useful in identifying and characterizing surface receptors and signaling molecules involved in brain processes and disorders: expression cloning, construction of chimeric fusion proteins, study of signal transduction, and application of the yeast two-hybrid system. A five year fellowship period will allow me to focus entirely on laboratory work, complete the proposed research program, and move towards an independent position. The diverse and innovative techniques utilized in the laboratory, many developed by Dr. Seed, will provide a strong foundation in molecular techniques necessary for independent work in the future. I plan a career in basic neuroscience research. I will focus on the cloning and elucidation of scarce neurosensory and neuronal receptors, isolating intracellular proteins involved in neuronal signaling, and studying mechanisms of signal transduction and their alteration in disease. I hope that the continuation of my proposed studies will provide me with sufficient experience and success to obtain the academic position and funding to pursue my research interests.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Unknown (K20)
Project #
5K20MH001147-05
Application #
2889816
Study Section
Molecular, Cellular, and Developmental Neurobiology Review Committee (MCDN)
Program Officer
Goldschmidts, Walter L
Project Start
1995-09-30
Project End
2000-08-31
Budget Start
1999-05-01
Budget End
2000-08-31
Support Year
5
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Benzing, T; Brandes, R; Sellin, L et al. (1999) Upregulation of RGS7 may contribute to tumor necrosis factor-induced changes in central nervous function. Nat Med 5:913-8
Gruning, W; Arnould, T; Jochimsen, F et al. (1999) Modulation of renal tubular cell function by RGS3. Am J Physiol 276:F535-43
Kim, E; Arnould, T; Sellin, L K et al. (1999) The polycystic kidney disease 1 gene product modulates Wnt signaling. J Biol Chem 274:4947-53
Kim, E; Arnould, T; Sellin, L et al. (1999) Interaction between RGS7 and polycystin. Proc Natl Acad Sci U S A 96:6371-6
Tsiokas, L; Arnould, T; Zhu, C et al. (1999) Specific association of the gene product of PKD2 with the TRPC1 channel. Proc Natl Acad Sci U S A 96:3934-9
Arnould, T; Sellin, L; Benzing, T et al. (1999) Cellular activation triggered by the autosomal dominant polycystic kidney disease gene product PKD2. Mol Cell Biol 19:3423-34
Arnould, T; Kim, E; Tsiokas, L et al. (1998) The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1. J Biol Chem 273:6013-8
Tsiokas, L; Kim, E; Arnould, T et al. (1997) Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc Natl Acad Sci U S A 94:6965-70